Skip to content

Comment on Cancer and Startups

Comments

Dennis Ritchie demonstrated the social value of tooling beyond all doubt. The Life Sciences hasn't had its Dennis Richie moment yet and it is a reason why cancer therapy hasn't advanced as far it could. Life sciences is in a crisis where a lab at Amgen with the best equipment money can buy could only replicate 11% of the results in 53 Nature published cancer papers.

The Life Sciences desperately needs computer scientists to learn their workflow and build the tooling for better more replicable science.

AboutSource Built by g1lg1l

Hackerly is an independent reader for Hacker News, built on the public HN API. Not affiliated with Y Combinator.